Valuation: Proteome Sciences plc

Market Cap 6.31M 8.42M 7.4M 6.88M 11.86M 811M 12.04M 81.69M 31.92M 399M 31.62M 30.94M 1.38B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 21.3M 28.42M 24.96M 23.21M 40.02M 2.74B 40.64M 276M 108M 1.35B 107M 104M 4.65B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 day-5.26%
1 week-5.26%
Current month+9.09%
1 month+6.51%
3 months+30.43%
6 months-44.27%
Current year-28.00%
1 week 1.3
Extreme 1.3
2.2
1 month 1.3
Extreme 1.3
2.3
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
8.71
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
19.75
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap.
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
6/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-5.26%-5.26%-40.79%-76.08% 8.42M
+2.29%+2.36%-18.56%-8.74% 180B
+1.46%+0.01%-10.47%-6.46% 107B
+1.58%+0.65%+6.73%+61.49% 60.29B
-1.13%-2.60%+27.02%+55.00% 50.19B
+2.22%-1.14%-15.63%-44.81% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-19.61%-44.95% 27.61B
-7.67%-8.39%+24.55%-12.97% 23.1B
+1.63%-1.73%-7.11%-8.13% 20.86B
Average -0.04%-2.54%-5.98%-9.52% 54.39B
Weighted average by Cap. +1.28%-0.40%-6.81%+1.11%

Financials

2024 2025
Net sales 4.89M 6.52M 5.73M 5.33M 9.18M 628M 9.32M 63.24M 24.71M 309M 24.48M 23.95M 1.07B 3.76M 5.01M 4.4M 4.09M 7.06M 483M 7.17M 48.61M 18.99M 237M 18.81M 18.41M 820M
Net income -3.41M -4.54M -3.99M -3.71M -6.4M -438M -6.5M -44.08M -17.22M -215M -17.06M -16.69M -744M -3.06M -4.08M -3.59M -3.34M -5.75M -393M -5.84M -39.61M -15.48M -193M -15.33M -15M -669M
Net Debt 13.39M 17.87M 15.7M 14.6M 25.17M 1.72B 25.55M 173M 67.72M 846M 67.08M 65.64M 2.93B 14.99M 20M 17.56M 16.33M 28.16M 1.93B 28.6M 194M 75.78M 947M 75.07M 73.46M 3.27B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
24/07/26 GBX 1.800 -5.26% 41,626
23/07/26 GBX 1.900 +4.40% 70,148
22/07/26 GBX 1.820 -4.21% 191,246
21/07/26 GBX 1.900 -2.56% 21,370
20/07/26 GBX 1.950 +2.63% 241,899